Candel Therapeutics (CADL) Stock Chart & Stock Price History → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free CADL Stock Alerts $10.83 +1.24 (+12.93%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Candel Therapeutics Stock Price Performance5 Day Performance+20.07%1 Month Performance+68.43%3 Month Performance+756.13%6 Month Performance+983.00%Year-To-Date Performance+636.73%1 Year Performance+560.37% Receive CADL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide CADL Stock Chart for Thursday, May, 9, 2024 CADL Chart by TradingView Candel Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$9.59$10.83+12.93%$10.83$9.441.15 million shs$317.86 million05/07/2024$8.85$9.59+8.36%$9.64$8.66762,586 shs$281.47 million05/06/2024$9.02$8.85-1.88%$10.86$8.431.88 million shs$259.72 million05/03/2024$8.43$9.02+7.00%$9.39$8.341.01 million shs$264.74 million05/02/2024$7.98$8.43+5.64%$8.78$7.441.25 million shs$247.42 million05/01/2024$7.05$7.98+13.19%$7.98$6.941.10 million shs$206.90 million Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$6.41$7.05+9.98%$7.30$6.251.11 million shs$206.92 million04/29/2024$6.39$6.41+0.31%$6.60$6.19366,102 shs$188.13 million04/26/2024$6.43$6.39-0.62%$6.60$6.02387,854 shs$187.55 million04/25/2024$6.05$6.43+6.28%$6.81$5.74745,769 shs$188.72 million04/24/2024$5.91$6.05+2.37%$6.33$5.71671,967 shs$177.57 million04/23/2024$5.54$5.91+6.68%$5.98$5.46456,083 shs$173.46 million04/22/2024$5.17$5.54+7.16%$5.68$5.10577,998 shs$162.58 million04/19/2024$5.46$5.17-5.31%$5.55$5.05521,041 shs$151.74 million04/18/2024$5.44$5.46+0.37%$5.99$5.22738,970 shs$160.25 million04/17/2024$5.89$5.44-7.64%$5.95$5.32846,927 shs$159.66 million04/16/2024$5.82$5.89+1.20%$6.34$5.631.07 million shs$172.87 million04/15/2024$6.66$5.82-12.61%$6.60$5.742.20 million shs$170.82 million04/12/2024$7.28$6.66-8.52%$7.50$6.576.79 million shs$195.47 million04/11/2024$5.10$7.28+42.75%$7.92$5.8464.09 million shs$213.67 million04/10/2024$5.09$5.10+0.20%$5.53$4.752.76 million shs$149.69 million04/09/2024$6.43$5.09-20.84%$6.52$4.883.71 million shs$149.39 million04/08/2024$6.64$6.43-3.16%$7.84$5.9715.51 million shs$188.70 million04/05/2024$6.40$6.64+3.75%$11.40$5.5883.92 million shs$194.88 million04/04/2024$1.68$6.40+280.95%$7.65$2.00141.80 million shs$187.84 million04/03/2024$1.69$1.68-0.59%$1.70$1.5685,199 shs$49.31 million04/02/2024$1.75$1.69-3.43%$1.77$1.6283,845 shs$48.88 million04/01/2024$1.58$1.75+10.76%$1.75$1.65100,336 shs$50.61 million03/29/2024$1.58$1.58$1.61$1.5330,621 shs$45.69 million03/28/2024$1.54$1.58+2.60%$1.61$1.5325,272 shs$45.69 million03/27/2024$1.50$1.54+2.67%$1.54$1.4630,835 shs$44.54 million03/26/2024$1.52$1.50-1.32%$1.54$1.4540,580 shs$43.38 million03/25/2024$1.50$1.52+1.33%$1.59$1.4733,316 shs$43.96 million03/22/2024$1.45$1.50+3.45%$1.55$1.4230,433 shs$43.38 million03/21/2024$1.50$1.45-3.33%$1.57$1.4033,507 shs$41.93 million03/20/2024$1.50$1.50$1.54$1.4727,533 shs$43.38 million03/19/2024$1.40$1.50+7.14%$1.55$1.4029,213 shs$43.38 million03/18/2024$1.50$1.40-6.67%$1.54$1.3469,864 shs$40.49 million03/15/2024$1.56$1.50-3.85%$1.60$1.4863,753 shs$43.38 million03/14/2024$1.57$1.56-0.64%$1.63$1.5335,519 shs$45.12 millionTrump Asset Seizure Threat Alert: Could Your Savings Be Next? (Ad)Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE03/13/2024$1.61$1.57-2.48%$1.63$1.5616,151 shs$45.40 million03/12/2024$1.68$1.61-4.17%$1.71$1.6013,981 shs$46.56 million03/11/2024$1.57$1.68+7.01%$1.74$1.55132,879 shs$48.59 million03/08/2024$1.53$1.57+2.61%$1.61$1.5370,855 shs$45.40 million03/07/2024$1.58$1.53-3.16%$1.59$1.5093,851 shs$44.25 million03/06/2024$1.63$1.58-3.07%$1.62$1.5659,868 shs$45.69 million03/05/2024$1.65$1.63-1.21%$1.66$1.5557,422 shs$47.14 million03/04/2024$1.70$1.65-2.94%$1.69$1.60177,409 shs$47.72 million03/01/2024$1.86$1.70-8.60%$1.88$1.68139,511 shs$49.16 million02/29/2024$1.78$1.86+4.49%$1.95$1.82111,538 shs$53.79 million02/28/2024$1.74$1.78+2.30%$1.79$1.7171,331 shs$51.48 million02/27/2024$1.78$1.74-2.25%$1.80$1.7139,148 shs$50.32 million02/26/2024$1.75$1.78+1.71%$1.81$1.7257,213 shs$51.48 million02/23/2024$1.76$1.75-0.57%$1.83$1.6584,937 shs$50.61 million02/22/2024$1.76$1.76$1.85$1.7081,262 shs$50.90 million02/21/2024$1.72$1.76+2.33%$1.77$1.6259,033 shs$50.90 million02/20/2024$1.72$1.72$1.77$1.6396,464 shs$49.74 million02/19/2024$1.72$1.72$1.80$1.60113,500 shs$49.74 million02/16/2024$1.74$1.72-1.15%$1.80$1.60113,562 shs$49.74 million02/15/2024$1.69$1.74+2.96%$1.84$1.61115,229 shs$50.32 million02/14/2024$1.80$1.69-6.11%$1.80$1.60252,763 shs$48.88 million02/13/2024$1.39$1.80+29.50%$1.94$1.441.91 million shs$52.06 million02/12/2024$1.43$1.39-2.80%$1.49$1.3036,772 shs$40.20 million02/09/2024$1.27$1.43+13.04%$1.44$1.2123,264 shs$41.36 million02/08/2024$1.25$1.27+1.20%$1.28$1.257,397 shs$36.58 million02/07/2024$1.29$1.25-3.10%$1.30$1.2517,688 shs$36.15 million Related Companies: STRO Stock Chart ADVM Stock Chart OPT Stock Chart INMB Stock Chart CMPX Stock Chart CRDF Stock Chart ABOS Stock Chart CHRS Stock Chart IPSC Stock Chart XFOR Stock Chart Receive CADL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CADL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.